Literature DB >> 18692554

Exclusive KRAS mutation in microsatellite-unstable human colorectal carcinomas with sequence alterations in the DNA mismatch repair gene, MLH1.

Yan Zhao1, Kaname Miyashita, Takayuki Ando, Yoshihiro Kakeji, Takeharu Yamanaka, Kenichi Taguchi, Toshikazu Ushijima, Shinya Oda, Yoshihiko Maehara.   

Abstract

Microsatellite instability (MSI) is regarded as reflecting defective DNA mismatch repair (MMR). MMR defects lead to an increase in point mutations, as well as repeat instability, on the genome. However, despite the highly unstable microsatellites, base substitutions in representative oncogenes or tumor suppressors are extremely infrequent in MSI-positive tumors. Recently, the heterogeneity in MSI-positive colorectal tumors is pointed out, and the 'hereditary' and 'sporadic settings' are proposed. Particularly in the former, base substitution mutations in KRAS are regarded as relatively frequent. We sequenced the KRAS gene in a panel of 76 human colorectal carcinomas in which the MSI status has been determined. KRAS mutations were detected in 22 tumors (28.9%). Intriguingly, all of the KRAS-mutant MSI-H (high) tumors harbored sequence alterations in an essential MMR gene, MLH1, which implies that KRAS mutation more frequently and almost exclusively occurs in MMR gene-mutant MSI-H tumors. Furthermore, in contrast with the prevailing viewpoint, some of these tumors are derived from sporadic colorectal cancer patients. The tight connection between MMR gene mutation and KRAS mutation may suggest previously unrecognized complexities in the relationship between MSI and the mutator phenotype derived from defective MMR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18692554     DOI: 10.1016/j.gene.2008.07.014

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  Prognosis and clinical characteristics of colorectal cancer patients with KRAS gene mutation: a 5-year follow-up study.

Authors:  Dongyang Yang; Xiaorong Lai; Fei Xu; Ying Li; Weiwei Jiang; Dong Ma
Journal:  Int J Clin Exp Pathol       Date:  2019-02-01

2.  Concurrent genetic alterations in DNA polymerase proofreading and mismatch repair in human colorectal cancer.

Authors:  Rintaro Yoshida; Kaname Miyashita; Mayuko Inoue; Akiyoshi Shimamoto; Zhao Yan; Akinori Egashira; Eiji Oki; Yoshishiro Kakeji; Shinya Oda; Yoshihiko Maehara
Journal:  Eur J Hum Genet       Date:  2010-12-15       Impact factor: 4.246

3.  Aberrant splicing caused by a MLH1 splice donor site mutation found in a young Japanese patient with Lynch syndrome.

Authors:  Masanobu Takahashi; Yoichi Furukawa; Hideki Shimodaira; Masato Sakayori; Takuya Moriya; Yoshihiro Moriya; Yusuke Nakamura; Chikashi Ishioka
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

4.  KRAS mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis.

Authors:  V Deschoolmeester; C Boeckx; M Baay; J Weyler; W Wuyts; E Van Marck; M Peeters; F Lardon; J B Vermorken
Journal:  Br J Cancer       Date:  2010-10-19       Impact factor: 7.640

5.  Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing.

Authors:  Allison M Cushman-Vokoun; Daniel G Stover; Zhiguo Zhao; Elizabeth A Koehler; Jordan D Berlin; Cindy L Vnencak-Jones
Journal:  Clin Colorectal Cancer       Date:  2013-06-14       Impact factor: 4.481

6.  Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer.

Authors:  Ryota Nakanishi; Jun Harada; Munkhbold Tuul; Yan Zhao; Koji Ando; Hiroshi Saeki; Eiji Oki; Takefumi Ohga; Hiroyuki Kitao; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  Int J Clin Oncol       Date:  2012-11-29       Impact factor: 3.402

7.  Modal variety of microsatellite instability in human endometrial carcinomas.

Authors:  Takako Eto; Yan Zhao; Akiko Maruyama; Kaname Miyashita; Aiko Yasui; Seiki Nakao; Kenichi Taguchi; Mototsugu Shimokawa; Shinya Oda; Toshiaki Saito
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-23       Impact factor: 4.553

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.